Haemophilia Scotland launched its Corporate Membership programme in 2022 to provide a more structured and transparent platform for companies to support our ongoing mission of improving the health and wellbeing of our members.
Through this initiative, our Corporate Members were able to demonstrate their commitment to the bleeding disorders community and receive recognition for their contribution to our work.
Our current members are:
Novo Nordisk UK Ltd has provided financial support to Haemophilia Scotland via platinum level Corporate Membership but has had no involvement in their work or content, apart from where otherwise stated
Roche Products Ltd and Chugai Pharma UK Ltd have provided financial support to Haemophilia Scotland via Gold level Corporate membership but has had no involvement in their work or content, apart from where otherwise stated.
SOBi Provide funding and support to Haemophilia Scotland as a Platinum Corporate Member. SOBi has no control or influence over the Haemophilia Scotland website or the material it produces, unless where stated.